Prelude Therapeutics Incorporated
PRLD
$1.36
$0.010.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -64.23% | -59.29% | -50.94% | -42.64% | -33.35% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.17% | 27.53% | -3.28% | -14.05% | -37.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -62.70% | -57.93% | -50.14% | -42.32% | -33.43% |
|
|
|||||
| Total Current Assets | -62.70% | -57.93% | -50.14% | -42.32% | -33.43% |
| Net Property, Plant & Equipment | -9.08% | -8.73% | -7.21% | -6.02% | 413.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.81% | -6.63% | -4.26% | -4.26% | -73.06% |
| Total Assets | -51.95% | -48.76% | -42.83% | -36.79% | -23.71% |
|
|
|||||
| Total Accounts Payable | -57.22% | -19.58% | 9.85% | 68.82% | 14.53% |
| Total Accrued Expenses | -6.35% | 12.79% | 13.48% | -2.60% | 22.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.11% | -1.02% | 21.25% | 82.31% | 473.47% |
| Total Finance Division Other Current Liabilities | 20.22% | -75.08% | -13.00% | -18.41% | -2.20% |
| Total Other Current Liabilities | 20.22% | -75.08% | -13.00% | -18.41% | -2.20% |
| Total Current Liabilities | -18.15% | -10.40% | 12.15% | 17.46% | 31.56% |
|
|
|||||
| Total Current Liabilities | -18.15% | -10.40% | 12.15% | 17.46% | 31.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.85% | -1.67% | -1.20% | -0.53% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.90% | -7.74% | -7.60% | -7.46% | -6.19% |
| Total Liabilities | -11.20% | -6.99% | 4.70% | 8.58% | 101.39% |
|
|
|||||
| Common Stock & APIC | 1.97% | 2.49% | 2.87% | 3.13% | 7.39% |
| Retained Earnings | -20.15% | -23.79% | -26.20% | -27.86% | -31.07% |
| Treasury Stock & Other | -98.80% | 99.66% | 105.11% | -84.30% | 127.60% |
| Total Common Equity | -62.58% | -58.39% | -51.04% | -44.55% | -34.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -62.58% | -58.39% | -51.04% | -44.55% | -34.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -62.58% | -58.39% | -51.04% | -44.55% | -34.34% |
|
|
|||||